The impact of health insurance coverage on pediatric diabetes management

Diabetes Research and Clinical Practice
Kupper A WintergerstMichael B Foster

Abstract

To examine the association between health insurance coverage, insulin management plans, and their impact on diabetes control in a pediatric type 1 diabetes mellitus clinic population. Retrospective cohort design drawn from the medical records of the Pediatric Endocrinology Clinic at the University of Louisville, Kentucky. Out of 701 patients, 223 had public insurance, and 478 had private insurance. 77% of publically insured used two or three injections per day vs. 40% private. Conversely, 58% of privately insured used a multiple daily injection (MDI) plan or insulin pump (vs. 21%). 84% of MDI patients had private insurance with 93% using insulin pens compared with 38% of publically insured. Mean HbA1c was 8.6% for privately insured vs. 9.8% public, p<0.0001. Privately insured MDI and pump patients had the lowest HbA1cs. Insurance type had a significant effect on the insulin management plan used and was the most significant factor in overall diabetes control. Limitations on insulin pen use and number of glucose test strips may play a role in the decreased use of MDI/insulin pumps by publicly insured patients. Addressing factors related to insurance type, including availability of resources, could substantially improve diabetes c...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jun 10, 1993·The New England Journal of Medicine·D M Nathan
Sep 18, 2003·JAMA : the Journal of the American Medical Association·Joseph W ThompsonJames E Bost
Jan 20, 2005·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Lisa SimpsonMarie C McCormick
Nov 12, 2005·Current Opinion in Pediatrics·Laura P Shone, Peter G Szilagyi
Oct 18, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Radovan Bogdanović
Nov 30, 2007·BMC Health Services Research·Asheley Cockrell Skinner, Michelle L Mayer
Aug 21, 2008·Expert Opinion on Drug Delivery·A PfütznerWc Lee
Dec 10, 2009·Vascular Health and Risk Management·Daniel J MooreJill H Simmons

❮ Previous
Next ❯

Citations

May 11, 2016·Pediatric Diabetes·Sara E WatsonKupper A Wintergerst
Sep 9, 2011·Journal of Medical Economics·Edward S Kimball, Mark Aagren
Oct 18, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·A R KhanolkarT Stephenson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.